Talkiatry Raises $20M Series A for In-Network Psychiatric Care

Talkiatry Secures $20 Million Series A Funding

Talkiatry has announced the successful completion of a $20 million Series A funding round, aimed at expanding its core strategy: providing psychiatry services that are fully integrated with insurance networks. This investment, spearheaded by Left Lane Capital and including participation from Dr. Richard Park, the founder and former CEO of CityMD, builds upon a prior $5 million financing.

Addressing a Critical Gap in Mental Healthcare

Founded by Robert Krayn and Dr. Georgia Gaveras, Talkiatry is a digital health startup focused on improving access to in-network psychiatric care. The company utilizes a comprehensive, ongoing care model. This begins with a virtual assessment to understand a patient’s needs, followed by matching them with a suitable psychiatrist.

The Innovation of In-Network Coverage

A key differentiator for Talkiatry is its commitment to securing insurance coverage for psychiatric services. Many insurance plans currently offer limited mental health benefits, and numerous qualified psychiatrists opt out of insurance networks due to low reimbursement rates and administrative burdens.

Consequently, patients often face long wait times with in-network providers or substantial out-of-pocket expenses – potentially reaching $300 per session – when seeking care from private practices.

A Focus on Clinical Quality

“Many have recognized the problem of psychiatrist accessibility,” Krayn stated. “The crucial question is whether solutions truly address the core issue, or merely offer workarounds.”

Krayn highlighted concerns regarding alternative approaches, such as relying on therapists and nurse practitioners instead of psychiatrists, which he believes can compromise the quality of clinical care. He emphasized the unique ability of psychiatrists to prescribe medication.

He also noted that competitors often concentrate on reducing out-of-pocket costs rather than eliminating them entirely.

Partnerships and Consumer Benefits

Talkiatry has established partnerships with major insurance providers, including United Healthcare, Aetna, and BlueCross BlueShield. Unlike some competitors, Talkiatry aims to provide a seamless in-network experience, minimizing additional costs for patients.

“While some platforms function as supplemental benefits to health insurance, they often come with restrictions – such as monthly fees or limited visit allowances,” Krayn explained. “Talkiatry operates like any other in-network physician, without these limitations.”

Building a Stable Provider Network

To ensure service stability, Talkiatry directly employs its psychiatrists as W-2 employees, rather than utilizing a contractor model. This approach, while potentially posing scaling challenges, prioritizes consistent care quality.

The company is actively recruiting psychiatrists with diverse backgrounds and navigating the complexities of local licensing requirements to expand its reach into new markets.

Competition and Market Landscape

Despite the presence of well-funded companies like Ginger and Lyra Health in the behavioral health space, Talkiatry is confident in its ability to gain traction. The sector continues to attract significant venture capital investment.

Competitors, such as Ginger, are also increasing their focus on in-network solutions, as evidenced by recent partnerships with AmeriHealth Caritas District of Columbia and Cigna.

Addressing the Supply-Demand Imbalance

Russell Glass, CEO and co-founder of Ginger, acknowledged the importance of in-network access but emphasized the ongoing shortage of mental health providers. He highlighted Ginger’s on-demand, virtual model as a means of addressing this imbalance, a challenge Talkiatry will also need to overcome.

Current Scale and Impact

Currently, Talkiatry’s platform includes 44 clinicians, with 33 being psychiatrists and the remainder nurse practitioners. The company has facilitated 30,000 patient visits since its inception.

• Funding: $20 million Series A
• Investors: Left Lane Capital, Dr. Richard Park, Sikwoo Capital Partners, Relevance Ventures
• Clinicians: 44 (33 Psychiatrists, 11 Nurse Practitioners)
• Visits Completed: 30,000